TrueMed is active in several specialties, including more common, as well as niche indications. Our Specialty Care teams work cross-functionally to address the unique needs of each specialty.
Rare and Ultra Rare Diseases
TrueMed works closely with a national network of Rare Disease specialists and centers, collaborating with healthcare professionals to educate and ensure fast diagnosis, help with therapy initiation, and support families on their journey.
We currently market therapies in both competitive settings and orphan designation which addressing serious metabolic conditions, enzyme deficiencies, and genetic deformities.
Matching the right therapy for the right patient can mean the difference between life or death, and it can also mean saving precious time, cost, and undue burden on patients and loved ones.
Biomarker-specific therapies and companion diagnostics are gaining importance as new therapeutic options emerge in certain specialties, while access restrictions become a larger consideration every day. Leveraging a personalized medicine approach can help healthcare professionals make better informed decisions and improve long-term outcomes for patients.
Early Access Programs
TrueMed operates several early-access programs for patients who need innovative therapies that are not currently registered in Israel, on a named patient basis.